CBA

Coastal Bridge Advisors’s UroGen Pharma URGN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$507K	Buy	+37,000	New	+$507K	0.04%	288
2025 Q1	–	Sell	-39,000	Closed	-$415K	–	392
2024 Q4	$415K	Sell	39,000 -1,500	-4%	-$16K	0.1%	103
2024 Q3	$514K	Buy	40,500 +2,000	+5%	+$25.4K	0.13%	93
2024 Q2	$646K	Buy	38,500 +1,500	+4%	+$25.2K	0.16%	81
2024 Q1	$555K	Sell	37,000 -750	-2%	-$11.3K	0.13%	93
2023 Q4	$566K	Sell	37,750 -750	-2%	-$11.3K	0.15%	86
2023 Q3	$539K	Buy	38,500 +768	+2%	+$10.8K	0.14%	86
2023 Q2	$391K	Buy	37,732 +732	+2%	+$7.58K	0.1%	101
2023 Q1	$342K	Hold	37,000	–	–	0.09%	113
2022 Q4	$328K	Hold	37,000	–	–	0.09%	110
2022 Q3	$308K	Hold	37,000	–	–	0.08%	117
2022 Q2	$303K	Sell	37,000 -1,000	-3%	-$8.19K	0.09%	111
2022 Q1	$331K	Sell	38,000 -36,000	-49%	-$314K	0.08%	108
2021 Q4	$1.02M	Buy	74,000 +37,000	+100%	+$510K	0.21%	65
2021 Q3	$622K	Hold	37,000	–	–	0.14%	72
2021 Q2	$565K	Hold	37,000	–	–	0.12%	82
2021 Q1	$721K	Hold	37,000	–	–	0.13%	63
2020 Q4	$667K	Hold	37,000	–	–	0.13%	63
2020 Q3	$714K	Hold	37,000	–	–	0.22%	57
2020 Q2	$966K	Hold	37,000	–	–	0.31%	49
2020 Q1	$660K	Buy	37,000 +17,308	+88%	+$309K	0.24%	59
2019 Q4	$657K	Buy	19,692 +2,000	+11%	+$66.7K	0.17%	61
2019 Q3	$469K	Hold	17,692	–	–	0.16%	80
2019 Q2	$636K	Buy	17,692 +7,692	+77%	+$277K	0.19%	63
2019 Q1	$369K	Buy	+10,000	New	+$369K	0.13%	84
2018 Q3	–	Sell	-19,230	Closed	-$957K	–	139
2018 Q2	$957K	Hold	19,230	–	–	0.39%	43
2018 Q1	$956K	Sell	19,230 -19,231	-50%	-$956K	0.35%	41
2017 Q4	$1.49M	Hold	38,461	–	–	0.47%	25
2017 Q3	$1.21M	Hold	38,461	–	–	0.4%	28
2017 Q2	$695K	Buy	+38,461	New	+$695K	0.23%	48